Atomoxetine Impurity 19(CAS: 18776-12-0)

Atomoxetine Impurity 19 (CAS: 18776-12-0) is a crystalline solid with a molecular weight of approximately 325.34 g/mol. It has a low water solubility and moderate solubility in organic solvents. The compound is relatively stable under normal conditions but may react with strong oxidizing agents. It is important to handle it under appropriate conditions to prevent degradation.

Atomoxetine Impurity 19 (CAS: 18776-12-0) is typically synthesized through a series of organic reactions involving functional group transformations and selective chemistry. Commonly, the synthesis involves protecting groups and acid-base reactions to achieve the desired impurity structure. The process often uses mild conditions and specific catalysts to ensure high yield and selectivity.

Atomoxetine Impurity 19 (CAS: 18776-12-0) is primarily used in the pharmaceutical industry, particularly in the development and quality control of Atomoxetine, a selective norepinephrine reuptake inhibitor used for the treatment of ADHD. It is also relevant in analytical chemistry for impurity profiling and stability studies.

When handling Atomoxetine Impurity 19 (CAS: 18776-12-0), it is essential to use appropriate personal protective equipment (PPE), including gloves and laboratory coats. Work should be conducted in a well-ventilated area or fume hood. Spills should be cleaned up immediately using appropriate procedures and materials. Always refer to the safety data sheet (SDS) for detailed handling and disposal information.